Mission
The overall mission of the HESI Risk Assessment Methodology (RAM) Technical Committee is to augment current exposure and risk assessment methods and model development efforts through projects, workshops, and scientific symposia aimed at addressing critical issues such as data needs, data characterization, and model evaluation.
Recognizing the need to integrate and better coordinate related programs, HESI and the ILSI Research Foundation held a brainstorming meeting in August 2009 with the goal of developing a structured plan to answer the question, “What are the critical issues that need to be addressed to advance science-based, human health risk assessment methodology.” As a result the project “Risk Assessment in the 21st Century (RISK21)” was formed. Click here for more information on this new program.
|
|
|
Committee Participation
2010 Government and Academic Participants
California Department of Pesticide Regulation
Canada Pest Management Regulatory Agency
Colorado State University
Health Canada
Imperial College London (UK)
US Centers for Disease Control and Prevention, ATSDR
US Department of Agriculture
US Environmental Protection Agency
US Food and Drug Administration
University of Guelph (Canada)
2010 Other Participants
Douglas L. Weed, LLC
2010 Committee Membership
Bayer CropScience
The Dow Chemical Company
Dow Corning
Eli Lilly (mixtures)
ExxonMobil Biomedical Sciences, Inc.
The Procter & Gamble Company (mixtures)
Syngenta Crop Protection, Inc.
|
|
Contact
Chair:
Dr. Rosemary Zaleski (Mixtures)
ExxonMobil Biomedical Sciences, Inc.
HESI Staff:
Dr. Michelle Embry, membry@ilsi.org
Ms. Regina Graham
202-659-3306
|
